Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$139K Buy
+10,874
New +$90.9K ﹤0.01% 3415
2026
Q1
Sell
-20,353
Closed -$67.6K 4493
2025
Q4
$67.6K Buy
+20,353
New +$57.5K ﹤0.01% 2752
2024
Q1
Sell
-3,059
Closed -$33.5K 2412
2023
Q4
$33.5K Buy
3,059
+1,882
+160% +$27.5K 0.01% 1295
2023
Q3
$24.8K Buy
+1,177
New +$24K ﹤0.01% 1352
2022
Q1
Sell
-1,456
Closed -$95K 999
2021
Q4
$95K Buy
1,456
+890
+157% +$86.4K 0.05% 475
2021
Q3
$80K Buy
+566
New +$72.1K 0.03% 579

Other funds holding QTTB

XTX Topco's QTTB Position: Q2 2026 in Review

XTX Topco opened a new position in Q32 Bio (QTTB) in Q2 2026: 10,874 shares worth $139K. The stake represents ﹤0.01% of the portfolio and ranks #3415 among its holdings. This is a return to the name: XTX Topco previously reported a position in QTTB as recently as Q4 2025.

XTX Topco first reported a position in QTTB in Q3 2021 and has held it in 6 quarters since. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • XTX Topco held 10,874 shares of Q32 Bio worth $139K as of Q2 2026.
  • Q32 Bio was a new XTX Topco position in Q2 2026.
  • Q32 Bio made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3415 holding.
  • XTX Topco first reported a position in Q32 Bio in Q3 2021 and has held it in 6 quarters since.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.